Axovant Sciences GmbH
Records under this name other than patents Axovant Sciences GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,034,859 | Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease Lapsed on the fee record Ended Jul 31, 2026 · High confidence | Lapsed on the fee record | Ended Jul 31, 2026 | High confidence |
| US 10,022,355 | Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 11,304,932 | Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease Lapsed on the fee record Ended Apr 19, 2026 · High confidence | Lapsed on the fee record | Ended Apr 19, 2026 | High confidence |
| US 7,452,888 | Quinoline Derivatives and Their Use as 5-HT6 Ligands Term ended Term ended Sep 21, 2024 · High confidence | Term ended | Term ended Sep 21, 2024 | High confidence |
| US 10,428,062 | Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors Lapsed on the fee record Ended Oct 1, 2023 · High confidence | Lapsed on the fee record | Ended Oct 1, 2023 | High confidence |
| US 10,370,370 | Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors Lapsed on the fee record Ended Aug 6, 2023 · High confidence | Lapsed on the fee record | Ended Aug 6, 2023 | High confidence |
| US 9,084,742 | Combinations Comprising 3-Phenylsulfonyl-8-Piperazinyl-1YL-QUINOLINE Lapsed on the fee record Ended Jul 21, 2023 · High confidence | Lapsed on the fee record | Ended Jul 21, 2023 | High confidence |
| US 7,977,337 | Quinoline Derivatives and Their Use as 5-HT6 Ligands Term ended Term ended Mar 25, 2023 · Medium confidence | Term ended | Term ended Mar 25, 2023 | Medium confidence |
| US 8,236,947 | Quinoline Derivatives and Their Use as 5-HT6 Ligands Term ended Term ended Mar 25, 2023 · Medium confidence | Term ended | Term ended Mar 25, 2023 | Medium confidence |
| US 10,183,938 | Geminal Substituted Quinuclidine Amide Compounds as Agonists of ALPHA-7 Nicotonic Acetylcholine Receptors Lapsed on the fee record Ended Jan 22, 2023 · High confidence | Lapsed on the fee record | Ended Jan 22, 2023 | High confidence |